Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 40 for “"Posaconazole"”.

  1. Ανάπτυξη αναλυτικών μεθόδων για την ταυτοποίηση και ποσοτικοποίηση της δραστικής ουσίας ποσακοναζόλης σε εναιωρήματα

    … to patients as a pharmaceutical suspension is posaconazole. Posaconazole is commercially available as an oral suspension 40 mg/mL, as a 18 mg/mL sterile concentrate for solution for intravenous infusion and as 100 mg gastro-resistant tablets. It is a novel member of the triazole antifungal …

    greece Repository record for Ανάπτυξη αναλυτικών μεθόδων για την ταυτοποίηση και ποσοτικοποίηση της δραστικής ουσίας ποσακοναζόλης σε εναιωρήματα (opens in a new tab)

  2. Impact of material attributes & process parameters on critical quality attributes of the amorphous solid dispersion products obtained using hot melt extrusion

    … and 4M grades. BCS class II drugs ibuprofen and posaconazole were selected due to their difference in glass transition temperature and lipophilicity. This study focused on investigation of the impact the material attributes and process parameters on the critical quality attributes in preparation …

    bradford Repository record for Impact of material attributes & process parameters on critical quality attributes of the amorphous solid dispersion products obtained using hot melt extrusion (opens in a new tab)

  3. Optimisation of Anti-Infective Medications in Patients Undergoing Allogeneic Haematopoietic Stem Cell Transplantation

    … first line prophylactic therapy was oral posaconazole. The second line drugs where oral therapy was unable to be administered were intravenous voriconazole (cohort 1) versus intravenous posaconazole (cohort 2). Subsequently a prospective observational pharmacokinetic study in adult alloHCT …

    adelaide Repository record for Optimisation of Anti-Infective Medications in Patients Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (opens in a new tab)

  4. Επιδημιολογική μελέτη σπανίων συστηματικών εν τω βάθει υφομυκητιάσεων και έλεγχος ευαισθησίας των υφομυκήτων στα κλασικά και νεότερα αντιμυκητιακά

    … B exhibited the lowest MICs, followed by posaconazole. Ravuconazole was active against eight of the Rhizopus isolates (MIC 1 mg/L). Resistance toamphotericin B (MIC ≥ 2 mg/L) and posaconazole (MICs ≥ 4 mg/L) was observed in five and threeRhizopus isolates, respectively. Among Fusarium …

    greece Repository record for Επιδημιολογική μελέτη σπανίων συστηματικών εν τω βάθει υφομυκητιάσεων και έλεγχος ευαισθησίας των υφομυκήτων στα κλασικά και νεότερα αντιμυκητιακά (opens in a new tab)

  5. Targeting CYP5122A1 and CYP51 for the Inhibition of Ergosterol Biosynthesis in Trypanosomatids

    … of CYP51 and CYP5122A1, e.g., clotrimazole and posaconazole, possess superior antileishmanial activity against L. donovani promastigotes whereas CYP51-selective inhibitors, e.g., fluconazole and voriconazole, have little effect on promastigote growth. In the search for CYP5122A1-selective …

    ku Repository record for Targeting CYP5122A1 and CYP51 for the Inhibition of Ergosterol Biosynthesis in Trypanosomatids (opens in a new tab)

  6. Epidemiology, treatment options and outcome of invasive infections caused by Aspergillus section Usti

    … receiving antifungal prophylaxis, especially posaconazole. In Switzerland, the latter is prescribed prophylactically to prevent the development of aspergillosis in bone marrow transplant recipients. The aim of this thesis was to describe the European epidemiology of IA caused by Aspergillus …

    greece Repository record for Epidemiology, treatment options and outcome of invasive infections caused by Aspergillus section Usti (opens in a new tab)

  7. Chemical Strategies for Bicyclic Peptide Formation

    … was screened for binders to the antifungal drug posaconazole. Adhirons are a non-antibody binding protein scaffold bearing variable peptide loops. The screening relied upon chemical derivatisation of the posaconazole structure to enable both screening and hit characterisation.

    whiterose Download PDF for Chemical Strategies for Bicyclic Peptide Formation (opens in a new tab)

  8. Ανθεκτικότητα των μυκήτων που αποικίζουν το γαστρεντερικό σωλήνα παιδιών με ειδικές παθήσεις (κακοήθη νοσήματα, νοσηλεία σε ΜΕΘ)

    … fluconazole, itraconazole, voriconazole, posaconazole and caspofungin were evaluated. Almost half (45%) of PICU children and 28% of POD children were already colonized on admission. Candida albicans was isolated from 56% and 82% of colonized children in PICU and POD respectively. …

    greece Repository record for Ανθεκτικότητα των μυκήτων που αποικίζουν το γαστρεντερικό σωλήνα παιδιών με ειδικές παθήσεις (κακοήθη νοσήματα, νοσηλεία σε ΜΕΘ) (opens in a new tab)

  9. Improvement of oral antineoplastic therapy by means of pharmacometric approaches & therapeutic drug monitoring

    … chronic GvHD. These patients often also receive posaconazole for invasive fungal prophylaxis leading to CYP3A4 mediated DDI between both substances. Different dosing recommendations from the FDA and EMA on the use of ruxolitinib in combination with posaconazole complicate clinical use. To …

    wurz-thes Repository record for Improvement of oral antineoplastic therapy by means of pharmacometric approaches & therapeutic drug monitoring (opens in a new tab)

  10. Investigating MCE Chemical Library Drugs for Combinational Therapies for Clinical Aspergillus fumigatus isolates

    … as voriconazole (VRC), itraconazole (ITC), and posaconazole (POS) with a reserve of Amphotericin B (AmB). In the past two decades, the emergence of resistance to azoles has contributed to a 90% mortality rate in resistant cases globally. In this report, we investigated the MedChem Express (MCE) …

    vt Repository record for Investigating MCE Chemical Library Drugs for Combinational Therapies for Clinical Aspergillus fumigatus isolates (opens in a new tab)

  11. Crystallization Inhibition in High Drug Loaded Amorphous Solid Dispersions

    … event. This view is verified in another example, posaconazole/poly(vinylpyrrolidone-co-vinyl acetate) (PVPVA) and posaconazole/PVP K25 ASDs, in Chapter 5. We close this dissertation by presenting some future directions in Chapter 6.

    umn Repository record for Crystallization Inhibition in High Drug Loaded Amorphous Solid Dispersions (opens in a new tab)

  12. Planejamento de novos inibidores da CYP51 do Trypanosoma Cruzi por estudos de QSAR

    … against this parasite’s target. One of them, posaconazole, was even tested in clinical trials that unfortunately could not prove a superior efficiency compared to benznidazole. Nevertheless, there are still many evidences that CYP51 is a great potential target to treat T. cruzi infection. The …

    brazil-ufrn Repository record for Planejamento de novos inibidores da CYP51 do Trypanosoma Cruzi por estudos de QSAR (opens in a new tab)

  13. Strategies for treating aspergillosis due to azole-resistant Aspergillus fumigatus: From the bench to the bedside.

    … 88%. Azole antifungals, such as voriconazole and posaconazole, are recommended first choice drugs to manage aspergillus diseases. However, acquired azole-resistance in A.fumigatus is an emerging problem that compromises the clinical efficacy of azole antifungals. Although azole resistance may …

    radboud Repository record for Strategies for treating aspergillosis due to azole-resistant Aspergillus fumigatus: From the bench to the bedside. (opens in a new tab) Download PDF for Strategies for treating aspergillosis due to azole-resistant Aspergillus fumigatus: From the bench to the bedside. (opens in a new tab)

  14. Discovery and development of novel antifungal agents for the treatment of Candida auris infections

    … (fluconazole, voriconazole, itraconazole, and posaconazole) and polyene (AmB). Mechanistic studies showed that the HIV protease inhibitors inhibited the fungal efflux pump, and interfered with glucose utilization, leading to reduced ATP levels in C. auris. Moreover, HIV protease inhibitors, in …

    vt Repository record for Discovery and development of novel antifungal agents for the treatment of Candida auris infections (opens in a new tab)

  15. Role of MDR3 in drug-induced cholestatic liver injury

    … hepatotoxic drugs tested, the antifungal azoles, posaconazole, itraconazole and ketoconazole significantly inhibited MDR3-mediated phospholipid secretion as well as BSEP-mediated bile salt secretion. Surprisingly, in parallel to MDR3 inhibition, posaconazole and itraconazole induced MDR3 protein …

    zurich Repository record for Role of MDR3 in drug-induced cholestatic liver injury (opens in a new tab)

  16. Chemogenomic profiling of the fungal pathogen Candida albicans

    … between anti-fungal drugs (fluconazole, posaconazole and amphotericin B) and a set of non-conditional mutants in non-essential C. albicans genes. Further, the utility of using the modified version (GRACE v1.0) of GRACE library in comparison to the parent GRACE library was assessed. …

    concordia Download PDF for Chemogenomic profiling of the fungal pathogen Candida albicans (opens in a new tab)

  17. Development and evaluation of a new Psysiologically Based Biopharmaceutics Modeling ( PBBM) approach for predicting oral drug product performance using the Open Systems Pharmacology Suite

    … This method was explored using suspensions of posaconazole (Noxafil®) anditraconazole (Sporanox®) in the fasted state, and the itraconazole amorphous solid dispersion (ASD) inboth fasted state and fed state. The resulting PBBMs for posaconazole and itraconazole enabling formulations closely …

    greece Repository record for Development and evaluation of a new Psysiologically Based Biopharmaceutics Modeling ( PBBM) approach for predicting oral drug product performance using the Open Systems Pharmacology Suite (opens in a new tab)

  18. Targeting Ergosterol Biosynthesis in Leishmania for Antileishmanial Drug Development: Functional Characterization of Leishmanial CYP51 and CYP5122A1

    … (4,14-DMZ), was purified from posaconazole-treated L. tarentolae cultures. Using 2D-NMR for structural elucidation, the stereochemistry of the 4 and 14 methyl groups on 4,14-DMZ was assigned. A branched de novo ergosterol biosynthesis pathway in Leishmania was proposed based on …

    ku Repository record for Targeting Ergosterol Biosynthesis in Leishmania for Antileishmanial Drug Development: Functional Characterization of Leishmanial CYP51 and CYP5122A1 (opens in a new tab)

  19. A Pharmacometrics Approach to Understanding Drug Disposition and Drug Interactions in Healthy Individuals and Patients Undergoing Roux-en-Y Gastric Bypass

    … for verapamil, a highly soluble inhibitor, and posaconazole, a poorly soluble inhibitor, to evaluate CYP3A- and P-gp-mediated DDIs pre- and post-RYGBS. For verapamil inhibition, RYGBS did not affect the fold-change of the inhibited AUC ratio or inhibited peak concentration ratio for either …

    washington Repository record for A Pharmacometrics Approach to Understanding Drug Disposition and Drug Interactions in Healthy Individuals and Patients Undergoing Roux-en-Y Gastric Bypass (opens in a new tab)

  20. Synthesis and characterization of new light emitting probes for sensitive detection of bio-molecules and live cells

    … fluorescent derivatives of the antifungal drugs, posaconazole and caspofungin, for diagnostic imaging of fungal cells. Invasive fungal infections (IFI's) are a growing threat to human health particularly, with increase in the number of immune-compromised patient population, such as organ …

    njit Repository record for Synthesis and characterization of new light emitting probes for sensitive detection of bio-molecules and live cells (opens in a new tab)

Page 1 of 2